/PRNewswire/ Abilita Bio, a leader in enabling the discovery of membrane protein-targeted therapeutics, announced today the company changed its name to.
/PRNewswire/ Abilita Bio, a leader in discovering and developing membrane protein-targeted therapeutics, announced today that it raised $7.5M in equity.